← SynDRA
MOCETINOSTAT
SynDRA canonical compound SYN0009094 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HDAC3 |
|---|
| Mechanism of action | HDAC inhibitor |
|---|
All known targets
- HDAC1
- HDAC2
- HDAC3
- HDAC11
- HDAC8
Mechanisms of action (all sources)
- histone deacetylase inhibitor
- HDAC1 INHIBITOR
- Histone deacetylase 1 inhibitor
- HDAC2 INHIBITOR
- Histone deacetylase 2 inhibitor
- HDAC3 INHIBITOR
- Histone deacetylase 3 inhibitor
- HDAC11 INHIBITOR
- Histone deacetylase 11 inhibitor
- HDAC8 INHIBITOR
- Histone deacetylase 8 inhibitor
Drug classes
- Histone Deacetylase Inhibitors
Cross-references
Synonyms
- MGCD-0103
- MGCD0103
- MGCD 0103
- MG-0103
- MG-4230
- MG-4915
- MG-5026
- MG0103
- MG4230
- MG4915
- MG5206
- Mocetinostat, MGCD0103
- N-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide
- N-(2-Aminophenyl)-4-((4-pyridin-3-ylpyrimidin-2-ylamino)methyl)benzamide
- N-(2-AMINOPHENYL)-4-([[4-(PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO]METHYL)BENZAMIDE
- Mocetinostat (MGCD0103)
- MGCD0103 (Mocetinostat)
- Mocetinostat (MGCD-0103)
- A6GWB8T96J
- CHEMBL272980
- 726169-73-9 (free base)
- N-(2-aminophenyl)-4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzamide
- Mocetinostat (USAN/INN)
- N-(2-aminophenyl)-4-[[[4-(3-pyridyl)pyrimidin-2-yl]amino]methyl]benzamide
- n-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide
- Benzamide, N-(2-aminophenyl)-4-(((4-(3-pyridinyl)-2-pyrimidinyl)amino)methyl)-
- N-(2-aminophenyl)-4-(((4-(pyridin-3-yl)pyrimidin-2-yl)amino)methyl)benzamide
- Mocetinostat [USAN]
- Mocetinostat [USAN:INN]
- UNII-A6GWB8T96J
- Mocetinostat (MGCD0103, MG0103)
- Horseradish peroxidase
- Myeloperoxidase (USAN)
- MGCD010,3Mocetinostat
- MOCETINOSTAT [INN]
- MGCD0103 - Mocetinostat
- MLS006010181
- MOCETINOSTAT [WHO-DD]
Look up MOCETINOSTAT in the interactive SynDRA portal →